Skip to main content
SpringerLink
Log in

Papillary Microcarcinoma of the Thyroid

  • Chapter
Book cover Practical Management of Thyroid Cancer

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Schlumberger M, Filetti S, Hay ID. Non-toxic goiter and thyroid neoplasia. In: Williams RH, Larsen PR (eds) Williams textbook of endocrinology, 10th edn. Philadelphia, PA: Saunders, 2003: 457–490.

    Google Scholar 

  2. Hazard JB. Small papillary carcinoma of the thyroid. A study with special reference to so-called nonencapsulated sclerosing tumor. Lab Invest 1960; 9:86–97.

    PubMed  CAS  Google Scholar 

  3. Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 1989; 63:908–911.

    PubMed  CAS  Google Scholar 

  4. Pelizzo MR, Piotto A, Rubello D, Casara D, Fassina A, Busnardo B. High prevalence of occult papillary thyroid carcinoma in a surgical series for benign thyroid disease. Tumori 1990; 76:255–257.

    PubMed  CAS  Google Scholar 

  5. Edis A. Natural history of occult thyroid cancer. In: DeGroot LJ, Frohman L, Kaplan E, Refetoff S (eds) Radiation-associated thyroid carcinoma. New York: Grune & Stratton, 1977: 155–160.

    Google Scholar 

  6. Rosai J, LiVolsi VA, Sobrinho-Simoes M, Williams ED. Renaming papillary microcarcinoma of the thyroid gland: the Porto proposal. Int J Surg Pathol 2003; 11:249–251.

    PubMed  Google Scholar 

  7. Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997; 126:226–231.

    PubMed  CAS  Google Scholar 

  8. Ross DS. Nonpalpable thyroid nodules — managing an epidemic. J Clin Endocrinol Metab 2002; 87:1938–1940.

    Article  PubMed  CAS  Google Scholar 

  9. Yang GC, LiVolsi VA, Baloch ZW. Thyroid microcarcinoma: fine-needle aspiration diagnosis and histologic follow-up. Int J Surg Pathol 2002; 10:133–139.

    PubMed  Google Scholar 

  10. Strate SM, Lee EL, Childers JH. Occult papillary carcinoma of the thyroid with distant metastases. Cancer 1984; 54:1093–1100.

    PubMed  CAS  Google Scholar 

  11. Sampson RJ. Prevalence and significance of occult thyroid cancer. In: DeGroot LJ, Frohman L, Kaplan E, Refetoff S (eds) Radiation-associated thyroid carcinoma. New York: Grune & Stratton, 1977: 137–153.

    Google Scholar 

  12. Yamamoto Y, Maeda T, Izumi K, Otsuka H. Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer 1990; 65:1173–1179.

    PubMed  CAS  Google Scholar 

  13. Mitselou A, Vougiouklakis T, Peschos D, Dallas P, Agnantis NJ. Occult thyroid carcinoma. A study of 160 autopsy cases. The first report for the region of Epirus-Greece. Anticancer Res 2002; 22:427–432.

    PubMed  Google Scholar 

  14. Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A “normal” finding in Finland. A systematic autopsy study. Cancer 1985; 56: 531–538.

    PubMed  CAS  Google Scholar 

  15. Lang W, Borrusch H, Bauer L. Occult carcinomas of the thyroid. Evaluation of 1,020 sequential autopsies. Am J Clin Pathol 1988; 90:72–76.

    PubMed  CAS  Google Scholar 

  16. Schottenfeld D, Gershman ST. Epidemiology of thyroid cancer — part I. Clin Bull 1977; 7:47–54.

    PubMed  CAS  Google Scholar 

  17. Nishyama R, Ludwig G, Thompson NW. The prevalence of small papillary thyroid carcinomas in 100 consecutive necropsies in an American population. In: DeGroot LJ, Frohman L, Kaplan E, Refetoff S (eds) Radiation-associated thyroid carcinoma. New York: Grune & Stratton, 1977: 123–135.

    Google Scholar 

  18. Sampson RJ, Woolner LB, Bahn RC, Kurland LT. Occult thyroid carcinoma in Olmsted County, Minnesota: prevalence at autopsy compared with that in Hiroshima and Nagasaki, Japan. Cancer 1974; 34:2072–2076.

    PubMed  CAS  Google Scholar 

  19. Fukunaga FH, Yatani R. Geographic pathology of occult thyroid carcinomas. Cancer 1975; 36:1095–1099.

    PubMed  CAS  Google Scholar 

  20. Fink A, Tomlinson G, Freeman JL, Rosen IB, Asa SL. Occult micropapillary carcinoma associated with benign follicular thyroid disease and unrelated thyroid neoplasms. Mod Pathol 1996; 9:816–820.

    PubMed  CAS  Google Scholar 

  21. Delides GS, Elemenoglou J, Lekkas J, Kittas C, Evthimiou C. Occult thyroid carcinoma in a Greek population. Neoplasma 1987; 34:119–125.

    PubMed  CAS  Google Scholar 

  22. de Benoist B, Andersson M, Takkouche B, Egli I. Prevalence of iodine deficiency worldwide. Lancet 2003; 362:1859–1860.

    Article  PubMed  Google Scholar 

  23. Harach HR, Escalante DA, Onativia A, Lederer Outes J, Saravia Day E, Williams ED. Thyroid carcinoma and thyroiditis in an endemic goitre region before and after iodine prophylaxis. Acta Endocrinol (Copenh) 1985; 108:55–60.

    PubMed  CAS  Google Scholar 

  24. Bacher-Stier C, Riccabona G, Totsch M, Kemmler G, Oberaigner W, Moncayo R. Incidence and clinical characteristics of thyroid carcinoma after iodine prophylaxis in an endemic goiter country. Thyroid 1997; 7:733–741.

    PubMed  CAS  Google Scholar 

  25. Lind P, Langsteger W, Molnar M, Gallowitsch HJ, Mikosch P, Gomez I. Epidemiology of thyroid diseases in iodine sufficiency. Thyroid 1998; 8:1179–1183.

    PubMed  CAS  Google Scholar 

  26. Langsteger W, Koltringer P, Wolf G, et al. The impact of geographical, clinical, dietary and radiation-induced features in epidemiology of thyroid cancer. Eur J Cancer 1993; 29A:1547–1553.

    Article  PubMed  CAS  Google Scholar 

  27. Feldt-Rasmussen U. Iodine and cancer. Thyroid 2001; 11:483–486.

    Article  PubMed  CAS  Google Scholar 

  28. Burgess JR, Dwyer T, McArdle K, Tucker P, Shugg D. The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978–1998) during a transition from iodine sufficiency to iodine deficiency. J Clin Endocrinol Metab 2000; 85:1513–1517.

    Article  PubMed  CAS  Google Scholar 

  29. Arnbjornsson E, Arnbjornsson A, Olafsson A. Thyroid cancer incidence in relation to volcanic activity. Arch Environ Health 1986; 41:36–40.

    Article  PubMed  CAS  Google Scholar 

  30. Duffy BJ Jr, Fitzgerald PJ. Thyroid cancer in childhood and adolescence; a report on 28 cases. Cancer 1950; 3:1018–1032.

    PubMed  Google Scholar 

  31. Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995; 141:259–277.

    PubMed  CAS  Google Scholar 

  32. Sampson RJ, Key CR, Buncher CR, Iijima S. Thyroid carcinoma in Hiroshima and Nagasaki. I. Prevalence of thyroid carcinoma at autopsy. JAMA 1969; 209:65–70.

    Article  PubMed  CAS  Google Scholar 

  33. Thompson DE, Mabuchi K, Ron E, et al. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958–1987. Radiat Res 1994; 137:S17–S67.

    PubMed  CAS  Google Scholar 

  34. Lund E, Galanti MR. Incidence of thyroid cancer in Scandinavia following fallout from atomic bomb testing: an analysis of birth cohorts. Cancer Causes Control 1999; 10:181–187.

    Article  PubMed  CAS  Google Scholar 

  35. Conrad R. Summary of thyroid findings in Marshallese 22 years after exposure to radioactive fallout. In: DeGroot LJ, Frohman L, Kaplan E, Refetoff S (eds) Radiation-associated thyroid carcinoma. New York: Grune & Stratton, 1977: 241–257.

    Google Scholar 

  36. Becker DV, Robbins J, Beebe GW, Bouville AC, Wachholz BW. Childhood thyroid cancer following the Chernobyl accident: a status report. Endocrinol Metab Clin North Am 1996; 25:197–211.

    Article  PubMed  CAS  Google Scholar 

  37. Kazakov VS, Demidchik EP, Astakhova LN. Thyroid cancer after Chernobyl. Nature 1992; 359:21.

    Article  PubMed  CAS  Google Scholar 

  38. Nikiforov Y, Gnepp DR. Pediatric thyroid cancer after the Chernobyl disaster. Pathomorphologic study of 84 cases (1991–1992) from the Republic of Belarus. Cancer 1994; 74:748–766.

    PubMed  CAS  Google Scholar 

  39. Baverstock K, Egloff B, Pinchera A, Ruchti C, Williams D. Thyroid cancer after Chernobyl’. Nature 1992; 359:21–22.

    Article  PubMed  CAS  Google Scholar 

  40. Mangano JJ. A post-Chernobyl rise in thyroid cancer in Connecticut, USA. Eur J Cancer Prev 1996; 5:75–81.

    PubMed  CAS  Google Scholar 

  41. Pottern LM, Stone BJ, Day NE, Pickle LW, Fraumeni JF Jr. Thyroid cancer in Connecticut, 1935–1975: an analysis by cell type. Am J Epidemiol 1980; 112:764–774.

    PubMed  CAS  Google Scholar 

  42. Simpson S. Headed south? Earth’s fading field could mean a magnetic flip soon. Sci Am 2002; 287:24.

    Article  PubMed  Google Scholar 

  43. Valana R, Cappelli C, Perini P, et al. Hyperthyroidism and concurrent thyroid cancer. Tumori 1999; 85:247–252.

    Google Scholar 

  44. Belfiore A, Garofalo MR, Giuffrida D, et al. Increased aggressiveness of thyroid cancer in patients with Graves’ disease. J Clin Endocrinol Metab 1990; 70:830–835.

    PubMed  CAS  Google Scholar 

  45. Mazzaferri EL. Thyroid cancer and Graves’ disease. J Clin Endocrinol Metab 1990; 70:826–829.

    Article  PubMed  CAS  Google Scholar 

  46. Pellegriti G, Belfiore A, Giuffrida D, Lupo L, Vigneri R. Outcome of differentiated thyroid cancer in Graves’ patients. J Clin Endocrinol Metab 1998; 83:2805–2809.

    Article  PubMed  CAS  Google Scholar 

  47. Hales IB, McElduff A, Crummer P, et al. Does Graves’ disease or thyrotoxicosis affect the prognosis of thyroid cancer. J Clin Endocrinol Metab 1992; 75:886–889.

    Article  PubMed  CAS  Google Scholar 

  48. Cantalamessa L, Baldini M, Orsatti A, Meroni L, Amodei V, Castagnone D. Thyroid nodules in Graves disease and the risk of thyroid carcinoma. Arch Intern Med 1999; 159:1705–1708.

    Article  PubMed  CAS  Google Scholar 

  49. Loh KC. Familial nonmedullary thyroid carcinoma: a meta-review of case series. Thyroid 1997; 7:107–13.

    Article  PubMed  CAS  Google Scholar 

  50. Burgess JR, Duffield A, Wilkinson SJ, et al. Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid. J Endocrinol Metab 1997; 82:345–348.

    Article  CAS  Google Scholar 

  51. Lupoli G, Vitale G, Caraglia M, et al. Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 1999; 353:637–639.

    Article  PubMed  CAS  Google Scholar 

  52. Fernandez-Real JM, Ricart W. Familial papillary thyroid microcarcinoma. Lancet 1999; 353:1973–1974.

    Article  PubMed  CAS  Google Scholar 

  53. Marchesi M, Biffoni M, Biancari F, et al. Familial papillary carcinoma of the thyroid: a report of nine firstdegree relatives of four families. Eur J Surg Oncol 2000; 26:789–791.

    Article  PubMed  CAS  Google Scholar 

  54. Rios A, Rodriguez JM, Canteras M, Galindo PJ, Balsalobre MD, Parrilla P. Risk factors for malignancy in multinodular goitres. Eur J Surg Oncol 2004; 30:58–62.

    Article  PubMed  CAS  Google Scholar 

  55. Musholt TJ, Musholt PB, Petrich T, Oetting G, Knapp WH, Klempnauer J. Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment. World J Surg 2000; 24:1409–1417.

    Article  PubMed  CAS  Google Scholar 

  56. Franssila KO, Harach HR. Occult papillary carcinoma of the thyroid in children and young adults. A systemic autopsy study in Finland. Cancer 1986; 58:715–719.

    PubMed  CAS  Google Scholar 

  57. Chow SM, Law SC, Au SK, et al. Changes in clinical presentation, management and outcome in 1348 patients with differentiated thyroid carcinoma: experience in a single institute in Hong Kong, 1960–2000. Clin Oncol (R Coll Radiol) 2003; 15:329–336.

    CAS  Google Scholar 

  58. Welch Dinauer CA, Tuttle RM, Robie DK, et al. Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clin Endocrinol (Oxf) 1998; 49:619–628.

    Article  CAS  Google Scholar 

  59. Collins BJ, Chiappetta G, Schneider AB, et al. RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions. J Clin Endocrinol Metab 2002; 87:3941–3946.

    Article  PubMed  CAS  Google Scholar 

  60. Newman KD, Black T, Heller G, et al. Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children’s Cancer Group. Ann Surg 1998; 227:533–541.

    Article  PubMed  CAS  Google Scholar 

  61. Alessandri AJ, Goddard KJ, Blair GK, Fryer CJ, Schultz KR. Age is the major determinant of recurrence in pediatric differentiated thyroid carcinoma. Med Pediatr Oncol 2000; 35:41–46.

    Article  PubMed  CAS  Google Scholar 

  62. Topliss D. Thyroid incidentaloma: the ignorant in pursuit of the impalpable. Clin Endocrinol (Oxf) 2004; 60:18–20.

    Article  Google Scholar 

  63. Chan BK, Desser TS, McDougall IR, Weigel RJ, Jeffrey RB Jr. Common and uncommon sonographic features of papillary thyroid carcinoma. J Ultrasound Med 2003; 22:1083–1090.

    PubMed  Google Scholar 

  64. Papini E, Guglielmi R, Bianchini A, et al. 2002 Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 87:1941–1946.

    Article  PubMed  CAS  Google Scholar 

  65. Leenhardt L, Hejblum G, Franc B, et al. Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules. J Clin Endocrinol Metab 1999; 84:24–28.

    Article  PubMed  CAS  Google Scholar 

  66. Nam-Goong IS, Kim HY, Gong G, et al. Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol (Oxf) 2004; 60:21–28.

    Article  Google Scholar 

  67. Cohen MS, Arslan N, Dehdashti F, et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 2001; 130:941–946.

    Article  PubMed  CAS  Google Scholar 

  68. Kang KW, Kim SK, Kang HS, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 2003; 88:4100–4104.

    Article  PubMed  CAS  Google Scholar 

  69. Sugitani I, Yanagisawa A, Shimizu A, Kato M, Fujimoto Y. Clinicopathologic and immunohistochemical studies of papillary thyroid microcarcinoma presenting with cervical lymphadenopathy. World J Surg 1998; 22:731–737.

    Article  PubMed  CAS  Google Scholar 

  70. Verge J, Guixa J, Alejo M, et al. Cervical cystic lymph node metastasis as first manifestation of occult papillary thyroid carcinoma: report of seven cases. Head Neck 1999; 21:370–374.

    Article  PubMed  CAS  Google Scholar 

  71. Coleman SC, Smith JC, Burkey BB, Day TA, Page RN, Netterville JL. Long-standing lateral neck mass as the initial manifestation of well-differentiated thyroid carcinoma. Laryngoscope 2000; 110:204–209.

    Article  PubMed  CAS  Google Scholar 

  72. Monchik JM, De Petris G, De Crea C. Occult papillary carcinoma of the thyroid presenting as a cervical cyst. Surgery 2001; 129:429–432.

    PubMed  CAS  Google Scholar 

  73. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 1992; 112:1139–1146; discussion 1146–1147.

    PubMed  CAS  Google Scholar 

  74. Baudin E, Travagli JP, Ropers J, et al. Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer 1998; 83:553–559.

    Article  PubMed  CAS  Google Scholar 

  75. Appetecchia M, Scarcello G, Pucci E, Procaccini A. Outcome after treatment of papillary thyroid microcarcinoma. J Exp Clin Cancer Res 2002; 21:159–164.

    PubMed  CAS  Google Scholar 

  76. Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid — prognostic significance of lymph node metastasis and multifocality. Cancer 2003; 98:31–40.

    Article  PubMed  Google Scholar 

  77. Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5cm in diameter: study of 299 cases. J Clin Endocrinol Metab 2004; 89:3713–3720.

    Article  PubMed  CAS  Google Scholar 

  78. Pearce EN, Braverman LE. Papillary thyroid microcarcinoma outcomes and implications for treatment. J Clin Endocrinol Metab 2004; 89:3710–3712.

    Article  PubMed  CAS  Google Scholar 

  79. Pelizzo MR, Boschin IM, Toniato A, et al. Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience. Nucl Med Commun 2004; 25:547–552.

    Article  PubMed  Google Scholar 

  80. Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003; 13:381–387.

    Article  PubMed  Google Scholar 

  81. Wada N, Duh QY, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 2003; 237:399–407.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrine Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

    William D. Drucker MD & Richard J. Robbins MD

Authors
  1. William D. Drucker MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard J. Robbins MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Ohio State University, Columbus, OH, USA

    Ernest L. Mazzaferri MD, MACP (Emeritus Professor) (Emeritus Professor)

  2. University of Florida, Gainsville, FL, USA

    Ernest L. Mazzaferri MD, MACP (Emeritus Professor) (Emeritus Professor)

  3. Department of Radiotherapy, Royal Marsden Hospital, London, UK

    Clive Harmer FRCR, FRCP (Head of Thyroid Unit) (Head of Thyroid Unit)

  4. Northern Centre for Cancer Treatment, Newcastle upon Tyne, UK

    Ujjal K. Mallick MS, FRCR (Vice-Chair) (Vice-Chair)

  5. Thyroid Cancer Subgroup, National Cancer Research Institute, UK

    Ujjal K. Mallick MS, FRCR (Vice-Chair) (Vice-Chair)

  6. Northern Cancer Network Thyroid Cancer Group, UK

    Ujjal K. Mallick MS, FRCR (Vice-Chair) (Vice-Chair)

  7. Department of Medicine, University of Newcastle upon Tyne, UK

    Pat Kendall-Taylor MD, FRCP (Emeritus Professor) (Emeritus Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag London Limited

About this chapter

Cite this chapter

Drucker, W.D., Robbins, R.J. (2006). Papillary Microcarcinoma of the Thyroid. In: Mazzaferri, E.L., Harmer, C., Mallick, U.K., Kendall-Taylor, P. (eds) Practical Management of Thyroid Cancer. Springer, London. https://doi.org/10.1007/1-84628-013-3_29

Download citation

  • DOI: https://doi.org/10.1007/1-84628-013-3_29

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-910-4

  • Online ISBN: 978-1-84628-013-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation